OTA Tomonori | Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
スポンサーリンク
概要
- OTA Tomonoriの詳細を見る
- 同名の論文著者
- Experimental Pathology and Chemotherapy Division, National Cancer Center Research Instituteの論文著者
関連著者
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Graduate School Of Medical Sciences Nagoya Ci
-
Asamoto M
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Asamoto Makoto
国立がんセンター
-
Asamoto Makoto
住友製薬大阪研究所
-
OTA Tomonori
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Ota Tomonori
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
TSUDA Hiroyuki
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Mutai Mamoru
First Department Of Pathology Nagoya City University Medical School
-
TSUDA Hiroyuki
Chemotherapy
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Tsuda H
Keio Univ. Yokohama‐shi Jpn
-
Tsuda Hiroyuki
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
NAITO Akihiro
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
ASAMOTO Makoto
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
TORIYAMA-BABA Hiroyasu
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Toriyama‐baba H
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Tsuda Hiroyuki
1st Dept. Pathol. Nagoya City Univ. Med. Sch.
-
Naito Akihiro
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Asamoto Makoto
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Tsuda H
Department Of Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Toriyama-baba Hiroyasu
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
KAKIZOE Tadao
National Cancer Center Hospital
-
ASAMOTO Makoto
Chemotherapy Division, National Cancer Center Research Institute
-
Kakizoe T
President National Cancer Center
-
Kakizoe T
National Cancer Center Hospital Tokyo
-
Mutai M
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Kakizoe Tadao
President National Cancer Center
-
A. Moore
Chemotherapy Division National Cancer Center Research Institute
-
NISHINO Hoyoku
Department of Biochemistry, Kyoto Prefectural University of Medicine
-
Kakizoe T
National Cancer Center Tokyo
-
Kakizoe Tadao
National Cancer Center
-
Asamoto Makoto
Chemotherapy Division National Cancer Center Research Institute
-
Tanaka Harunari
Division Of Oncological Pathology Aichi Cancer Center Research Institute
-
TAKASUKA Nobuo
Chemotherapy
-
BABA-TORIYAMA Hiroyasu
Chemotherapy
-
Tsuda Hiroyuki
First Department Of Pathology Nagoya City University Medical School
-
Tsuda Hiroyuki
Department Of Molecular Toxicology Nagoya City University
-
Nishino Hoyoku
Department Of Biochemistry And Molecular Biology Graduate School Of Medical Science Kyoto Prefectura
-
SEKINE Kazunori
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
OHNISHI Takamasa
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
ANDO Akira
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
OCHIYA Takahiro
Section for Studies on Metastasis, National Cancer Center Research Institute
-
KRUTOVSKIKH Vladimir
Chemotherapy Division, National Cancer Center Research Institute
-
SEKINE Kazunori
Chemotherapy Division, National Cancer Center Research Institute
-
WATANABE Emiko
Chemotherapy Division, National Cancer Center Research Institute
-
NAKAMURA Joe
Chemotherapy Division, National Cancer Center Research Institute
-
KIM Dae
Chemotherapy Division, National Cancer Center Research Institute
-
OTA Tomonori
Chemotherapy Division, National Cancer Center Research Institute
-
MASUDA Mitsuharu
Cancer Prevention Division, National Cancer Center Research Institute
-
SUGIMOTO Hajime
Cancer Prevention Division, National Cancer Center Research Institute
-
HOKAIWADO Naomi
Experimental Pathology and Chemotherapy Division, National Cancer Center Research Institute
-
Tsuda H
Dep. Of Molecular Toxicology Nagoya City Univ.
-
Baba-toriyama Hiroyasu
Chemotherapy Division National Cancer Center Research Institute
-
Hokaiwado Naomi
Department Of Experimental Pathology And Tumor Biology Nagoya City University Graduate School Of Med
-
Hokaiwado Naomi
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Kawaguchi Takanori
2nd Department Of Pathology Fukushima Medical University School Of Medicine
-
Krutovskikh Vladimir
Chemotherapy Division National Cancer Center Research Institute
-
Tanaka H
Department Of Cancer Control And Statistics Osaka Medical Center For Cancer And Cardiovascular Disea
-
Tsuda Hiroyuki
Molecular Toxicology Nagoya City University Graduate School Of Medical Sciences
-
Maeda M
Ibl
-
Mutai Mamoru
Safety Research Laboratory (kazusa) Mitsubishi Tanabe Pharma Corporation
-
Nakamura Joe
Chemotherapy Division National Cancer Center Research Institute
-
Watanabe Emiko
Chemotherapy Division National Cancer Center Research Institute
-
Kim Dae
Chemotherapy Division National Cancer Center Research Institute
-
Takasuka Nobuo
Cancer Prevention Basic Res. Project National Cancer Center Res. Inst.
-
Ota T
National Cancer Center Res. Inst. Tokyo
-
Murakoshi M
Lion Corp. Kanagawa Jpn
-
Ochiya Takahiro
Section For Studies On Metastasis National Cancer Center Research Institute
-
Ohnishi Takamasa
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Ando Akira
Experimental Pathology And Chemotherapy Division National Cancer Center Research Institute
-
Sugimoto Hajime
Cancer Prevention Division National Cancer Center Research Institute
-
OCHIYA Takahiro
Section for Studies of Metastasis, National Cancer Center Research Institute
著作論文
- Transgenic Rats Carrying Human c-Ha-ras Proto-oncogene Are Highly Susceptible to N-Nitorosomethylbenzylamine Induction of Esphageal Tumorigenesis
- Inhibition of Azoxymethane-initiated Colon Tumor by Bovine Lactoferrin Administration in F344 Rats
- Mammary Carcinomas Induced in Human c-Ha-ras Proto-oncogene Transgenic Rats Are Estrogen-independent, but Responsive to d-Limonene Treatment